Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Silzle

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Therapeutische Umschau. Revue Therapeutique|March 16, 2022
[How Myelodysplastic Syndrome is Diagnosed]Tobias Silzle
Blood|March 29, 2014
A hairy issueTobias Silzle, Felicitas Hitz
Blood|March 30, 2023
A spiky issueTobias Silzle, Christina Appenzeller
American Journal of Hematology|August 6, 2011
Pyrazinamide-induced sideroblastic anemiaGiuseppe Colucci, Tobias Silzle, Max Solenthaler
European Journal of Haematology|August 10, 2013
Posterior reversible encephalopathy syndrome during induction chemotherapy for acute myeloid leukaemiaTobias Silzle, Nicola Glaser-Gallion, Felicitas Hitz
International Journal of Cancer|November 26, 2003
The fibroblast: sentinel cell and local immune modulator in tumor tissueTobias Silzle, Gwendalyn J Randolph, Marina Kreutz, et al.
European Journal of Immunology|May 6, 2003
Tumor-associated fibroblasts recruit blood monocytes into tumor tissueTobias Silzle, Marina Kreutz, Marcus A Dobler, et al.
Cytometry. Part B, Clinical Cytometry|January 25, 2014
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesisMichael Daskalakis, Giuseppe Colucci, Peter Keller, et al.
Cytometry. Part B, Clinical Cytometry|March 29, 2014
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesisMichael Daskalakis, Giuseppe Colucci, Peter Keller, et al.
Blood Cancer Journal|August 11, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patientsTobias Silzle, Sabine Blum, Esther Schuler, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|March 16, 2022
[How Myelodysplastic Syndrome is Diagnosed]Tobias Silzle
Blood|March 29, 2014
A hairy issueTobias Silzle, Felicitas Hitz
Blood|March 30, 2023
A spiky issueTobias Silzle, Christina Appenzeller
American Journal of Hematology|August 6, 2011
Pyrazinamide-induced sideroblastic anemiaGiuseppe Colucci, Tobias Silzle, Max Solenthaler
European Journal of Haematology|August 10, 2013
Posterior reversible encephalopathy syndrome during induction chemotherapy for acute myeloid leukaemiaTobias Silzle, Nicola Glaser-Gallion, Felicitas Hitz
International Journal of Cancer|November 26, 2003
The fibroblast: sentinel cell and local immune modulator in tumor tissueTobias Silzle, Gwendalyn J Randolph, Marina Kreutz, et al.
European Journal of Immunology|May 6, 2003
Tumor-associated fibroblasts recruit blood monocytes into tumor tissueTobias Silzle, Marina Kreutz, Marcus A Dobler, et al.
Cytometry. Part B, Clinical Cytometry|January 25, 2014
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesisMichael Daskalakis, Giuseppe Colucci, Peter Keller, et al.
Cytometry. Part B, Clinical Cytometry|March 29, 2014
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesisMichael Daskalakis, Giuseppe Colucci, Peter Keller, et al.
Blood Cancer Journal|August 11, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patientsTobias Silzle, Sabine Blum, Esther Schuler, et al.
Pageof 3